Cheng Andrew

Cheng Andrew is listed in filings as Director at Vera Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to Vera Therapeutics, Inc. (VERA) and Akero Therapeutics, Inc. (AKRO). The current snapshot covers public activity from Feb 11, 2025 to May 26, 2026. Reported amounts are shown as $296.7K to $654.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.